UnitedHealth Group Incorporated (NYSE:UNH) PT Raised to $235.00 at Citigroup Inc.

UnitedHealth Group Incorporated (NYSE:UNH) had its price objective increased by Citigroup Inc. from $213.00 to $235.00 in a research note released on Wednesday, October 18th. They currently have a buy rating on the healthcare conglomerate’s stock.

Other research analysts also recently issued research reports about the stock. Barclays PLC raised their target price on shares of UnitedHealth Group from $200.00 to $217.00 and gave the company an overweight rating in a research report on Wednesday, July 19th. Leerink Swann reissued a buy rating and set a $240.00 target price (up previously from $225.00) on shares of UnitedHealth Group in a research report on Wednesday, October 18th. Zacks Investment Research raised shares of UnitedHealth Group from a hold rating to a buy rating and set a $219.00 target price on the stock in a research report on Thursday, September 21st. Cowen and Company reissued a buy rating on shares of UnitedHealth Group in a research report on Friday, July 14th. Finally, Cantor Fitzgerald lifted their price objective on shares of UnitedHealth Group to $225.00 and gave the stock an overweight rating in a research report on Wednesday, October 18th. Three research analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company. The stock has a consensus rating of Buy and an average target price of $215.27.

Shares of UnitedHealth Group (NYSE UNH) traded up 1.65% during midday trading on Wednesday, hitting $212.60. The company had a trading volume of 4,385,348 shares. The company has a market capitalization of $210.26 billion, a price-to-earnings ratio of 24.14 and a beta of 0.63. The company’s 50-day moving average price is $198.85 and its 200 day moving average price is $187.48. UnitedHealth Group has a 12-month low of $136.22 and a 12-month high of $212.77.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, beating analysts’ consensus estimates of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The company had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. During the same quarter last year, the business posted $2.17 EPS. The firm’s revenue for the quarter was up 8.7% on a year-over-year basis. Equities research analysts predict that UnitedHealth Group will post $9.99 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “UnitedHealth Group Incorporated (NYSE:UNH) PT Raised to $235.00 at Citigroup Inc.” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2017/10/28/unitedhealth-group-incorporated-unh-price-target-raised-to-235-00-at-citigroup-inc.html.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total transaction of $969,900.00. Following the completion of the sale, the director now owns 76,058 shares of the company’s stock, valued at $14,753,730.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Thomas E. Roos sold 975 shares of the company’s stock in a transaction on Thursday, October 19th. The stock was sold at an average price of $205.47, for a total transaction of $200,333.25. Following the sale, the insider now directly owns 24,630 shares of the company’s stock, valued at approximately $5,060,726.10. The disclosure for this sale can be found here. Insiders have sold 77,149 shares of company stock valued at $15,182,242 in the last ninety days. Insiders own 0.89% of the company’s stock.

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Regal Wealth Group Inc. grew its holdings in shares of UnitedHealth Group by 0.4% in the second quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock valued at $138,000 after purchasing an additional 3 shares during the period. Jackson Grant Investment Advisers Inc. grew its holdings in shares of UnitedHealth Group by 0.4% in the first quarter. Jackson Grant Investment Advisers Inc. now owns 1,097 shares of the healthcare conglomerate’s stock valued at $180,000 after purchasing an additional 4 shares during the period. RB Capital Management LLC grew its holdings in shares of UnitedHealth Group by 0.4% in the second quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock valued at $321,000 after purchasing an additional 7 shares during the period. Altfest L J & Co. Inc. grew its holdings in shares of UnitedHealth Group by 0.3% in the second quarter. Altfest L J & Co. Inc. now owns 2,963 shares of the healthcare conglomerate’s stock valued at $549,000 after purchasing an additional 10 shares during the period. Finally, Parkside Financial Bank & Trust grew its holdings in shares of UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after purchasing an additional 12 shares during the period. 86.09% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply